Instrumento Inactivo

Acciones Vitae Pharmaceuticals Inc

Acciones

Precio de cierre Nasdaq Otros sitios de cotización
- ^USD	-

Vitae Pharmaceuticals : Allergan and Vitae Pharmaceuticals Announce Expiration of HSR Waiting Period for Allergan's Proposed Acquisition of Vitae	17/10/16
Brower Piven Commences An Investigation Into The Proposed Sale Of Vitae Pharmaceuticals, Inc. And Encourages Shareholders To Contact The Firm For Additional Information	15/09/16
Brower Piven Commences An Investigation Into The Proposed Sale Of Vitae Pharmaceuticals, Inc. And Encourages Investors To Contact The Firm For Additional Information	15/09/16
NASDAQ Comp : Wall Street termine dans le rouge, Apple monte encore	14/09/16
Vitae Pharmaceuticals : Allergan to Acquire Vitae Pharmaceuticals Adding Innovative Development Programs for Dermatologic Conditions	14/09/16

Directores	Puesto	Edad	Desde
Ambrose Bailey PSD	President	60	25/10/16
Carole A. Sable CTO	Chief Tech/Sci/R&D Officer	62	06/06/16
John Grosso BRD	Director/Board Member	-	-

Administradores	Puesto	Edad	Desde
John Grosso BRD	Director/Board Member	-	-

Sector

	Varia. 1 de ene.	Capi.
CSL LIMITED	-2,84 %	90,45 mil M
SAMSUNG BIOLOGICS CO.,LTD.	+3,95 %	41,45 mil M
BIOGEN INC.	-10,51 %	33,57 mil M
UCB	+60,58 %	25,73 mil M
BIOMARIN PHARMACEUTICAL INC.	-20,09 %	14,73 mil M
INCYTE CORPORATION	-8,92 %	12,82 mil M
BEIJING WANTAI BIOLOGICAL PHARMACY ENTERPRISE CO., LTD.	-11,46 %	11,7 mil M
CHONGQING ZHIFEI BIOLOGICAL PRODUCTS CO., LTD.	-43,05 %	11,44 mil M
SWEDISH ORPHAN BIOVITRUM AB	+5,17 %	8792,23 M